Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 8Tumor-Agnostic 4CNS 4Genitourinary 3Gastrointestinal 3Breast 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Dermatologic 1

Conditions

Prostatic Neoplasms 3

Interventions

pembrolizumab 182Magnetic Resonance Spectroscopy 161Specimen Handling 134enzalutamide 125Nivolumab 118Gemcitabine 96Docetaxel 92Radiosurgery 91Prednisone 81Androgen Antagonists 81Abiraterone Acetate 79Radiotherapy 75apalutamide 66Cisplatin 65darolutamide 62Ipilimumab 61Biopsy 61abiraterone 57cabozantinib 55Carboplatin 55Leuprolide 52enfortumab vedotin 50Radiation 47Pluvicto 45Standard of Care 44atezolizumab 41Surveys and Questionnaires 38acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Restraint, Physical × Genitourinary × 1 year × Clear all
NCT06500169 2026-06-03

GREENS

University of Southern California

Phase NA Recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002540 2026-04-28

Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
76,685 enrolled 23 charts
Genitourinary

Prostatic Neoplasms

NCT07074405 2026-03-27

AccAI

Centre Hospitalier Universitaire de Liege

Phase NA Completed
51 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡